C202-3630 Screening compound: 7-(3-bromophenyl)-3-[(3-methylphenyl)carbamoyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid

C202-3630 Screening compound: 7-(3-bromophenyl)-3-[(3-methylphenyl)carbamoyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid
C202-3630 Screening compound: 7-(3-bromophenyl)-3-[(3-methylphenyl)carbamoyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound C202-3630
7-(3-bromophenyl)-3-[(3-methylphenyl)carbamoyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C202-3630

Molecular Formula

C21H17BrN4O3 (C21 H17 BrN4 O3)

Compound Name

7-(3-bromophenyl)-3-[(3-methylphenyl)carbamoyl]-4H,7H-pyrazolo[1,5-a]pyrimidine-5-carboxylic acid

IUPAC name

7-(3-bromophenyl)-3-[(3-methylphenyl)carbamoyl]-4H7H-pyrazolo[15-a]pyrimidine-5-carboxylic acid

SMILES

Cc1cccc(NC(c2c(NC(C(O)=O)=CC3c4cccc(Br)c4)n3nc2)=O)c1

InChI

InChI=1S/C21H17BrN4O3/c1-12-4-2-7-15(8-12)24-20(27)16-11-23-26-18(13-5-3-6-14(22)9-13)10-17(21(28)29)25-19(16)26/h2-11,18,25H,1H3,(H,24,27)(H,28,29)/t18-/m0/s1

InChI Key

NNUBNUSRSPLTKM-SFHVURJKSA-N

MDL Number (MFCD)

MFCD14731712

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

453.3

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.037

Distribution Coefficient, logD

1.789

Water Solubility, LogSw

-4.03

Polar Surface Area

76.545

Acid Dissociation Constant (pKa)

5.15

Base Dissociation Constant (pKb)

-2.77

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

9.50

C202-3630 in Drug Discovery

Included in Screening Libraries

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Nuclear receptors
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C202-3630 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C202-3630?
Check Price and Availability of C202-3630, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C202-3630 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C202-3630
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C202-3630
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C202-3630 available by request